Truxima
FDA approves first Rituxan biosimilar courtesy of Teva and Celltrion
November 29, 2018Sales and Marketing FDA, Genentech, Rituxan, Roche, Teva, Truxima, biosimilars, celltrion
The FDA has announced the first US approval of a biosimilar version of Genentech’s Rituxan (rituximab), awarding marketing approval to …
Celltrion’s Rituxan biosimilar gets unanimous backing from FDA committee
October 11, 2018Sales and Marketing FDA, Oncologic Drugs Advisory Committee, Rituxan, Roche, Truxima
FDA approval looks to be in reach for Celltrion, as an advisory committee for the US regulator voted unanimously to …
Celltrion biosimilar proves effectiveness in lymphoma and rheumatoid arthritis
June 14, 2017Research and Development Cellltrion, Truxima, biosimilar, lymphoma, rheumatoid arthritis, rutiximab
Celltrion Healthcare has revealed new data which validates its biosimilar Truxima (CT-P10) as non-inferior to its reference product rituximab in …
